# US 2023/0056088 A1 · Deoxyhemoglobin in magnetic resonance imaging

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0056088 A1
- Document ID: US20230056088A1
- Status: Published application
- Kind: A1
- Application number: 17/789,732
- Filed: 2020-12-31
- Published: 2023-02-23
- Earliest claimed: 2019-12-31
- Inventors: Adrian P. CRAWLEY; Rohan DHARMAKUMAR; James DUFFIN; Joseph Arnold FISHER; David MIKULIS; Julien POUBLANC; Behzad SHARIF; Olivia SOBCZYK; Kamil ULUDAG; Chau VU; John WOOD; Hsin-Jung YANG
- Web page: https://patentgrep.com/patent/US20230056088A1

## CPC

- A61B 5/0816: {Measuring devices for examining respiratory frequency (measuring frequency of electric signals G01R23/00)}
- G01R 33/281: {Means for the use of in vitro contrast agents (G01R33/282 takes precedence; involving use of a contrast agent in MR imaging G01R33/5601; in vivo contrast agents A61K49/0002)}
- A61B 5/0044: {for the heart}
- A61B 5/0263: {using NMR}
- A61B 5/055: involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
- A61B 5/14542: {for measuring blood gases (A61B5/14551 takes precedence)}
- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 5/7257: {using Fourier transforms}
- A61B 5/7289: {Retrospective gating, i.e. associating measured signals or images with a physiological event after the actual measurement or image acquisition, e.g. by simultaneously recording an additional physiological signal during the measurement or image acquisition}
- G01R 33/50: based on the determination of relaxation times {, e.g. T1 measurement by IR sequences; T2 measurement by multiple-echo sequences}
- G01R 33/58: Calibration of imaging systems, e.g. using test probes {, Phantoms; Calibration objects or fiducial markers such as active or passive RF coils surrounding an MR active material}
- A61B 2560/0223: of calibration, e.g. protocols for calibrating sensors
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01R: MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES (indicating correct tuning of resonant circuits H03J3/12)

## Abstract

Deoxyhemoglobin in a subject may be modulated to act as a contrast agent for use in magnetic resonance imaging. Sequential gas delivery may be applied to adjust the level of deoxyhemoglobin in the subject. A suitable magnetic resonance imaging (MRI) pulse sequence that is sensitive to magnetic field inhomogeneities, such as a blood-oxygen-level dependent (BOLD) sequence, may be used to detect deoxyhemoglobin as a contrast agent.

## Claims

### Claim 1

A method comprising:
generating a change in deoxyhemoglobin in a subject;
conducting magnetic resonance imaging on the subject; and
using the deoxyhemoglobin of the subject as a contrast agent for a weighted imaging of the magnetic resonance imaging.

### Claim 2 (depends on 1)

The method of claim 1, further comprising synchronizing the level of deoxyhemoglobin with data of the magnetic resonance imaging.

### Claim 3 (depends on 1)

The method of claim 1, further comprising controlling one or both of breathing rate and gas composition to exhibit different temporal and/or localized responses in the level of deoxyhemoglobin in the subject during the magnetic resonance imaging.

### Claim 4 (depends on 1)

The method of claim 1, wherein the weighted imaging comprises a weighting imaging (T2*) of a transverse relaxation time (T2).

### Claim 5 (depends on 1)

The method of claim 1, wherein generating the change in the deoxyhemoglobin in the subject comprises varying a partial pressure of oxygen in the lungs of the subject.

### Claim 6 (depends on 1)

The method of claim 1, further comprising using a single or multiple gradient-echo for contrast preparation and a single-shot signal indicative of a dynamic change of deoxyhemoglobin in response to a rapid and controlled change in oxygen concentration provided for inhalation by the subject.

### Claim 7 (depends on 1)

The method of claim 1, further comprising using single or multiple spin-echo contrast preparation and a single-shot signal to detect a weighted change in a magnetic resonance imaging signal caused by a change in deoxyhemoglobin to measure blood flow, blood volume, transit time, or a combination of such.

### Claim 8 (depends on 1)

The method of claim 1, further comprising using a combination gradient echo and spin echo for contrast preparation and a single shot signal indicative of mixed T2 and T2*-weighted changes in a magnetic resonance imaging signal caused by a change in deoxyhemoglobin to measure blood flow, blood volume, transit time, or a combination of such.

### Claim 9 (depends on 1)

The method of claim 1, further comprising deriving from a magnetic resonance imaging signal responsive to a change in deoxyhemoglobin a peak signal change, an onset, a time to peak, a full width half maximum, a recovery half time, an area under the curve, or a combination of such.

### Claim 10 (depends on 1)

The method of claim 1, further comprising applying a Fourier analysis to a characteristic of a magnetic resonance imaging signal to define a set of voxels.

### Claim 11 (depends on 10)

The method of claim 10, further comprising applying the Fourier analysis to generate a generate map of an arterial transit time, a capillary transit time, a venous transit time, or a combination of such for use in diagnosis of an arteriovenous fistula, a collateral vessel, or both.

### Claim 12 (depends on 10)

The method of claim 10, further comprising applying time-delay information from a phase map of the Fourier analysis to form a static visualization of vasculature.

### Claim 13 (depends on 10)

The method of claim 10, further comprising applying time-delay information from a phase map of the Fourier analysis to form a static visualization of vasculature.

### Claim 14 (depends on 10)

The method of claim 10, further comprising applying time-delay information from a phase map of the Fourier analysis to output a video of a dynamic contrast change as contrast passes continuously among different vascular levels.

### Claim 15 (depends on 1)

The method of claim 1, further comprising computing a perfusion quantity based on a response to a bolus inspiration that changes the deoxyhemoglobin in the subject.

### Claim 16 (depends on 15)

The method of claim 15, wherein the perfusion quantity comprises a cerebral blood flow (CBF), a cerebral blood volume (CBV), a mean transit time (MTT), an arterial arrival time (ATT), or a combination of such.

### Claim 17 (depends on 1)

The method of claim 1, further comprising computing an Arterial Input Function (AIF).

### Claim 18 (depends on 1)

The method of claim 1, further comprising determining a capillary transit time heterogeneity (CTH) with reference to a distribution of transit time within a region or voxel of a signal of the magnetic resonance imaging.

### Claim 19 (depends on 1)

The method of claim 1, further comprising computing a performance status of the left ventricle of the subject, wherein the performance status comprises a cardiac output ({dot over (Q)}), a stroke volume (SV), or a left ventricular ejection fraction (LVEF).

### Claim 20

Use of deoxyhemoglobin of the subject as a contrast agent in magnetic resonance imaging.

### Claim 21

A method of controlling deoxyhemoglobin in a subject, the method comprising:
providing a gas for the subject to inhale to obtain a target lung partial pressure of oxygen and a target lung partial pressure of carbon dioxide to obtain a target level of deoxyhemoglobin in the subject's blood.

### Claim 22 (depends on 21)

The method of claim 21, further comprising using a sequential gas delivery apparatus to deliver the gas to the subject.

### Claim 23 (depends on 21, 22)

The method of claim 21 or 22, wherein the target level of deoxyhemoglobin is arterial.

### Claim 24 (depends on 21, 22)

The method of claim 21 or 22, wherein the target level of deoxyhemoglobin is venous.

### Claim 25 (depends on 21, 22, 23, 24)

The method of any of claims 21 to 24, wherein providing the gas for the subject to inhale causes a rapid change in lung partial pressure of oxygen and lung partial pressure of carbon dioxide to cause a rapid change in deoxyhemoglobin.

### Claim 26 (depends on 21, 22, 23, 24, 25)

The method of any of claims 21 to 25, further comprising using dynamic end-tidal forcing to obtain one or both of the target lung partial pressure of oxygen and the target lung partial pressure of carbon dioxide.

### Claim 27 (depends on 21, 22, 23, 24, 25, 26)

The method of any of claims 21 to 26, further comprising prospective targeting of the target lung partial pressure of oxygen independent of breath volume and frequency.

### Claim 28 (depends on 21, 22, 23, 24, 25, 26, 27)

The method of any of claims 21 to 27, further comprising prospective targeting of the target lung partial pressure of carbon dioxide independent of breath volume and frequency.

### Claim 29 (depends on 21)

The method of claim 21, further comprising controlling one or both of breathing rate and gas composition to obtain durations of stimulus and baseline levels of deoxyhemoglobin.

### Claim 30 (depends on 29)

The method of claim 29, further comprising obtaining durations of stimulus and baseline levels of deoxyhemoglobin for a plurality of subjects to generate an atlas.

### Claim 31

Use of hypoventilation and/or breath holding for a subject to generate deoxyhemoglobin in the subject for use as contrast agent in magnetic resonance imaging.

### Claim 32

A method of calibrating magnetic resonance imaging, the method comprising:
controlling blood deoxyhemoglobin in a subject by administering a gas that provides a lung partial pressure of oxygen and a lung partial pressure of carbon dioxide to the subject;
capturing a calibrating magnetic resonance imaging signal while controlling the blood deoxyhemoglobin in the subject;
obtaining a relationship of the blood deoxyhemoglobin to the calibrating magnetic resonance imaging signal; and
applying the relationship to a subsequent magnetic resonance imaging signal for a tissue to obtain tissue oxygenation information.

### Claim 33 (depends on 32)

The method of claim 32, comprising administering the gas to provides different levels of lung partial pressure of oxygen and lung partial pressure of carbon dioxide.

### Claim 34 (depends on 32)

The method of claim 32, wherein the calibrating magnetic resonance imaging signal is obtained from the subject's aorta.

### Claim 35 (depends on 32)

The method of claim 32, wherein the calibrating magnetic resonance imaging signal is obtained from the subject's vena cava or right atrium.
